Skip to content

Patency, coagulation, and quality of life after deep venous stenting

Patency, coagulation, and quality of life after deep venous stenting - Life after a venous stent

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49454
Enrollment
107
Registered
2020-07-10
Start date
2020-07-06
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deep vein thrombosis thrombosed leg

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Venous stent placement between 2006 and 2020 at the EMC in the common femoral vein, iliac veins and/or inferior vena cava - Signed informed consent - Patients aged 18 years and older - Sufficient understanding of the Dutch language.

Exclusion criteria

Exclusion criteria: - Non-dedicated venous stents - No follow-up due to death shortly after stent placement from a malignancy (some stents were used for comfort care) - Insufficient understanding of the Dutch language - No informed consent.

Design outcomes

Primary

MeasureTime frame
Patency rates of venous stents and predictors for reinterventions or occlusions Secondary outcomes: prevalence of coagulation disorders in the study population, comparison of coagulation disorders between patients with MT syndrome and right sided or distal DVTs, and quality of life (SF-36 and CIVIQ-20).

Secondary

MeasureTime frame
Prevalence of coagulation disorders in the study population, comparison of coagulation disorders between patients with MT syndrome and right sided or distal DVTs, and quality of life (SF-36 and CIVIQ-20).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)